Featured Editorial

  1. Why Patients Drop Out And How To Stop Them 4/8/2026

    From scheduling friction to silent financial stress, patient dropout derails trials. Here’s what’s causing it and the tech helping sites fight back.

  2. Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials 4/6/2026

    Predictive analytics is transforming clinical trial operations, from enrollment forecasting to risk-based monitoring. Here’s what sponsors need to know.

  3. AI In Clinical Trials: Real Impact, Real Limits, What's Next 4/2/2026

    Claude’s ClinicalTrials.gov connector changes how sponsors access trial data, but does it change outcomes? A recruitment expert weighs in on impact and what’s still missing.

  4. RWD Helps Researchers Include More Patients In Lymphoma Research 4/2/2026

    Andrew Evens, DO, MBA, explores how outcomes research and collaboration across academic networks, registries, and industry partners are advancing more inclusive, data-informed approaches to lymphoma research.

  5. RWE Is Ready — Decision Making For Pharmaceuticals Isn't 4/1/2026

    Gorana Capkun of Merck, KGaA, Darmstadt, Germany discusses the growing role of real-world evidence in clinical trials, highlighting a gap between regulatory momentum and pharma adoption— and the challenge of turning data into better decisions.

  6. Building A Future-Proof, GxP-Compliant IT Infrastructure 3/31/2026

    Learn how a structured IT evaluation framework can help companies model total compliance costs, request vendor qualification evidence, and embed governance requirements into infrastructure selection.

  7. Unlocking Biopharma Innovation With Real-World Evidence 3/30/2026

    Discover how how federated data networks, platform aggregators, and collaborative partnerships have evolved to meet the data demands of modern product development, regulatory strategy, and commercial success.

  8. AI And Clinical Trial Recruitment: Can It Fix The Funnel? 3/26/2026

    Anthropic’s ClinicalTrials.gov connector gives Claude real-time access to trial data. But can conversational AI actually improve patient recruitment strategy?

  9. Elsa's AI Model Migration: Technical, Compliance, And Regulatory Risks For Sponsors (Part 2) 3/26/2026

    In the second part of their series on Elsa AI model migration, Kimberly Chew, Esq., and Michael Yang, Esq., analyze the risks to compliance and data residency, as well as the integrity of the regulatory record.

  10. From Real-World Data To Real-World Impact: Building The Evidence Capability Pharma Actually Needs 3/25/2026

    Learn how companies that treat RWE as an operational capability will be better positioned to design more efficient trials, accelerate therapy adoption, strengthen payer negotiations, and demonstrate value across the healthcare ecosystem.